Prominent Canadian researcher in Denmark: Why I left a top job in California
Nete Huus's email & phone | NMD Pharma ApS's Senior Scientist email
NMD Pharma
NMD Pharma raises €38M (~USD 47 Million) SERIES A Financing to Advance Treatments of Neuromuscular Disorders
Big deal: NMD flexes series A muscles - University Venturing: News, Data, and Events - Global University Venturing
Thomas H. Pedersen - CEO at NMD Pharma | The Org
NMD Pharma - PIR International
NMD Pharma A/S | LinkedIn
NMD PHARMA's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile
UNIVERSITY OF COPENHAGEN Project title Novel Treatments of Neuromuscular Disease Mentor 1 Pontus Gourdon, MSc & PhD,
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
NMD Pharma begins first clinical trial: "Our entire team can be enormously proud"
NMD Pharma - Capnova
NMD Pharma company information, funding & investors | Dealroom.co
Tagged with NMDPharma - EY Danmark
Novo Holdings · NMD Pharma
NMD Pharma Information | NMD Pharma Profile
NMD Pharma
Thomas Pedersen - BioLeader Interview - PIR International
NMD Pharma Initiates Combined Phase I/II Clinical trial — NMD Pharma
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
NMD Pharma
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
Monique Schiersing - Director at NMD Pharma | The Org
